Modulation of HIV-1 Production by Immune Checkpoint Ligands
Corresponding Organization : Swiss Vaccine Research Institute
Variable analysis
- Presence or absence of recombinant IC ligands at 100 μg/mL
- Combination of two IC-ligands
- HIV-1 production as measured by HIV-1 RNA levels
- Sorted LN PD-1^high and PD-1^- memory (CD45RA^-) CD4 T-cell populations (2 × 10^5 cells)
- Culture conditions: 37°C, 5% CO2, 96-well U-bottom plates
- Stimulation with anti-CD3 (10 μg/ml) and anti-CD28 (10 μg/ml)
- Presence of 75 nM emtricitabine to prevent re-infection of stimulated CD4 T cells
- Positive control: Presence of recombinant IC ligands
- Negative control: Absence of recombinant IC ligands
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!